Abstract

To compare the number of admissions, clinical features and therapeutic outcomes of patients treated for acute ST-segment elevation myocardial infarction (STEMI), before and after the COVID-19 pandemic state of emergency in Peru. Observational analytical study of retrospective cohorts, derivated from the PEruvian Registry of ST-segment Elevation Myocardial Infarction II (PERSTEMI II). We compared the patients treated for STEMI, between 45 days before and during the first 45 days of the COVID-19 state of emergency in Peru. During the first 45 days of the COVID-19 state of emergency, the team found a 59% decrease on the number of admissions for STEMI. There was a larger proportion of patients with high blood pressure and dyslipidemia. We noticed a decreasing trend in the access to reperfusion therapies (73% vs. 66.6%); the fibrinolysis was the most commonly used therapy. The most frequent reason for no reperfusion was the late onset >24 hours (41.7%, p=0.004). There was a trend of time reduction to first medical contact and less ischemia time to reperfusion. A lower incidence of post-infarction heart failure was registered. The mortality was similar in both groups (3.4% vs. 2.7%). COVID-19 pandemic in Peru has generated a significant reduction of STEMI admissions and a trend in less use of reperfusion therapies. The late onset of patients was the most common reason of not reperfusion.

Highlights

  • To compare the number of admissions, clinical features and therapeutic outcomes of patients treated for acute ST-segment elevation myocardial infarction (STEMI), before and after the COVID-19 pandemic state of emergency in Peru

  • We compared the patients treated for STEMI, between 45 days before and during the first 45 days of the COVID-19 state of emergency in Peru

  • COVID-19 pandemic in Peru has generated a significant reduction of STEMI admissions and a trend in less use of reperfusion therapies

Read more

Summary

Artículo Original

Objetivo: Comparar el número de ingresos, características clínicas y resultados terapéuticos de los Afiliaciones de los Autores: 1 Servicio de Cardiología. Pacientes atendidos por infarto de miocardio con elevación del segmento ST (IMCEST) antes y durante el estado de emergencia por COVID-19 en Perú. Se comparó los pacientes atendidos por IMCEST 45 días antes y durante los 45 días iniciales del estado de emergencia por COVID-19 en Perú. Resultados: Durante los primeros 45 días del período de emergencia se encontró una disminución del 59% en el número de ingresos por IMCEST. Conclusiones: La pandemia por COVID-19 en el Perú ha generado una disminución significativa en los Conflicto de interés: No se reporta conflicto de interés. La presentación tardía de los pacientes fue la causa más frecuente de no reperfusión. Impact of the COVID-19 pandemic on ST- elevation myocardial infarction care in Peru

Methods
Results
Conclusions
Material y Método
Edad promedio Sexo masculino Antecedentes y Factores de Riesgo
ICP de la ANRI Ninguna terapia de reperfusión
Referencias Bibliográficas

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.